跳至主要内容
临床试验/JPRN-C000000391
JPRN-C000000391未知未知

An open label randomized controlled trial on the preemptive risedronate intervention for renal transplant patients receiving glucocorticoid - The Preemptive Risedronate Intervention for those Undergoing Steroid therapy after Renal Transplantation (PRIUS-RTx Study)

Department of Advanced Technology for Transplantation, Osaka University School of Medicine0 个研究点目标入组 50 人开始时间: 2006年4月1日最近更新:
适应症

试验速览

阶段
未知
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Previous history of bisphosphonate treatment and/or hormone replacement therapy within one year before entry 2. Contraindication for risedronate or active vitamin D 3. Not suitable to the clinical trial as judged by a physician

研究者

发起方
Department of Advanced Technology for Transplantation, Osaka University School of Medicine

相似试验